Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Myeloma Treatment With Thalidomide. Three Randomized Studies on Thalidomide as Induction Treatment Before Autotransplant (MY-TAG) or With a Conventional Chemotherapy (MY-DECT) and as Consolidation/Maintenance at Plateau Phase (MY-PLAT).

NCT01070862 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT01070862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01070862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Myeloma Treatment With Thalidomide. Three Randomized Studies on Thalidomide as Induction Treatment Before Autotransplant (MY-TAG) or With a Conventional Chemotherapy (MY-DECT) and as Consolidation/Maintenance at Plateau Phase (MY-PLAT).
Lead sponsor
University Hospital, Caen
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2003
Completion date
December 31, 2009
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma de novo treatment